Dr. Eunice Wang was invited to discuss results of a phase II clinical trial of crenolanib for adults with AML at the ASH 2017 annual meeting, and Dr. Kara Kelly, senior author of an oral abstract on outcomes disparities among children and...
11-Dec-2017 9:05 AM EST Add to Favorites
Society for Immunotherapy of Cancer Spearheads Initiative to Align Management of Immunotherapy Side Effects
The first consensus recommendations on recognition and clinical management of immune-related side effects from cancer immunotherapy are published today in the Journal for ImmunoTherapy of Cancer (JITC).
21-Nov-2017 5:05 PM EST Add to Favorites
Researchers at Roswell Park Cancer Institute have initiated a clinical trial based on a unique two-pronged strategy for arming the immune system to more effectively attack cancer cells.
2-Nov-2017 2:05 PM EDT Add to Favorites
In a new study published in Cell Reports, scientists report an unexpected finding — that the oncogene FOXQ1 suppresses the growth of melanoma cells.
28-Sep-2017 4:15 PM EDT Add to Favorites
Roswell Park Cancer has joined the Oncology Research Information Exchange Network, a unique research partnership among North America’s top cancer centers. Members of ORIEN contribute to a shared databank and collaborate on clinical research in...
14-Sep-2017 5:05 PM EDT Add to Favorites
A new study from Roswell Park Cancer Institute reports that women with breast cancer who took multivitamin supplements were less likely to develop chemotherapy-induced neuropathy.
12-Sep-2017 3:05 PM EDT Add to Favorites
New research led by a team from Roswell Park Cancer Institute and published in the journal Nature Methods reports the development of the first tool for detecting changes in GTP levels in living cells.
12-Sep-2017 2:05 PM EDT Add to Favorites
Beta Blockers May Hold Key to Unleashing Potential of Checkpoint Inhibitors, Roswell Park Team Shows
In new research published in the journal Cancer Research, a team from Roswell Park has shown that "beta blocker" drugs appear to be an effective means of reducing beta-2 receptor signaling and, in the process, may improve the efficacy of...
30-Aug-2017 5:05 PM EDT Add to Favorites
25-Jan-2017 10:05 AM EST
Dr. Igor Puzanov of @RoswellPark Cancer Institute Avail. To Comment on Chan/Zuckerberg $30b Pledge for #Medicalresearch
22-Sep-2016 3:05 PM EDT
Roswell Park's Dr. James Marshall Available to Interpret, Comment on Who Statement on Processed Meats and Cancer Risk
27-Oct-2015 5:05 PM EDT
Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT